IndiaTickerWelcure Drugs & Pharmaceuticals Ltd - 524661 - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs & Pharmaceuticals Ltd Held On Today I.E. Tuesday, 14Th July, 2026.BSE · exchange filing · pdf
Source filing Company dossier
Welcure Drugs & Pharmaceuticals
BSE:WELCURE · ISIN INE331C01025
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Welcure Drugs & Pharmaceuticals
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Welcure Drugs & Pharmaceuticals Ltd - 524661 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerBSE · exchange filing · pdf
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs & Pharmaceuticals Limited Held On Today I.E. Friday, 19Th June, 2026BSE · exchange filing · pdf
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Of The Welcure Drugs And Pharmaceuticals Limited Held Today I.E. Friday, 29Th May, 2026BSE · exchange filing · pdf
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Audited Standalone Financial Result For The Quarter And Year Ended 31St March, 2026BSE · financial results · pdf
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Board Meeting Intimation for Consideration And Approval Of The Audited Financial Results For The Quarter/Year Ended 31St March, 2026 Along With Statement Of Assets And Liabilities And Cash Flow Statement For The Year Ended 31St March, 2026.BSE · financial results · pdf
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure ABSE · exchange filing · pdf
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs &
Pharmaceuticals Limited Held On Today I.E. Thursday, 12Th February, 2026BSE · exchange filing · pdf
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Unaudited Financial Results For The 3Rd Quarter Ended On 31St December, 2025.BSE · financial results · pdf
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Board Meeting Intimation for Intimation Of Meeting Of The Board Of Directors To Be Held On Thursday, February 12, 2026.BSE · exchange filing · pdf
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs And Pharmaceuticals
Limited Held Today I.E. Saturday, December 06, 2025BSE · exchange filing · pdf
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Postponement Of The Meeting Of The Rights Issue Committee Of Welcure Drugs And Pharmaceuticals Limited Which Was To Be Held Today I.E. Monday, December 05, 2025BSE · corporate action · pdf
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs And Pharmaceuticals
Limited Held Today I.E. Monday, December 01, 2025BSE · exchange filing · pdf
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Announcement under Regulation 30 (LODR)-Resignation of DirectorBSE · exchange filing · pdf
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Board Meeting Intimation for Intimation Of Rights Issue Committee Meeting To Be Held On 05Th December, 2025 For
Deciding Issue Price And Other Terms Of The Rights IssueBSE · corporate action · pdf
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Board Meeting Intimation for Postponement Of Board Meeting Which Was To Be Held On Thursday, 27Th November, 2025BSE · exchange filing · pdf
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday, November 27, 2025BSE · exchange filing · pdf
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Result- Unaudited Financial Statement For The Quarter And Half Year Ended 30Th September 2025BSE · financial results · pdf
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs & Pharmaceuticals Limited Held On Today I.E. Thursday, 13Th November, 2025.BSE · exchange filing · pdf
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Board Meeting Intimation for Considering And Approving The Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2025 Along With Limited Review Report ('Financial Results').BSE · financial results · pdf
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Board Meeting Outcome for Outcome Of The Board Meeting-Allotment Of Bonus SharesBSE · exchange filing · pdf
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Board Meeting Outcome for Outcome Of Board Meeting Held On 07 October,2025 Of Welcure Pharmaceuticals LimitedBSE · exchange filing · pdf
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Intimation Of Record Date For Ascertaining The Eligibility Of The Shareholders Entitled To Stock Split/ Sub-Division Of Shares & Bonus Issue.BSE · corporate action · pdf
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportBSE · exchange filing · pdf
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Shareholder Meeting / Postal Ballot-Outcome of AGMBSE · exchange filing · pdf
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Announcement under Regulation 30 (LODR)-Meeting UpdatesBSE · exchange filing · pdf
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Board Meeting Outcome for Outcome Of The Board MeetingBSE · exchange filing · pdf
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Board Meeting Intimation for Notice Regarding Postponement And Rescheduling Of The Board MeetingBSE · exchange filing · pdf
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Board Meeting Intimation for To Take On Record And Deliberate Upon The Letter Of Intent (LOI) Received From Telexcell Trade PTE LTD, SingaporeBSE · exchange filing · pdf
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing